Trump administration targets deals in dozens of industries before midterms

The Trump administration is implementing an unprecedented 'whole-of-government' strategy to reshape U.S. industrial policy, actively engaging up to 30 critical sectors, including pharmaceuticals and semiconductors, to bolster domestic manufacturing and secure supply chains. This involves direct negotiations with companies, offering incentives like tariff relief in exchange for increased production or, notably, taking equity stakes, as seen with Intel (10%) and MP Materials (15%). The initiative is supported by a proposed expansion of the International Development Finance Corporation's financing to $250 billion and a new Commerce Department Investment Accelerator, signaling a significant shift from traditional free-market principles towards direct government intervention and ownership in strategic industries.

Analysis

The Trump administration is executing a significant pivot in U.S. industrial policy, moving from a traditionally hands-off approach to direct, interventionist dealmaking across approximately 30 strategic sectors. This 'whole-of-government' strategy aims to reshore manufacturing, reduce dependency on China, and secure supply chains in areas like pharmaceuticals, semiconductors, and critical minerals. The administration is leveraging its authority to negotiate directly with companies such as Eli Lilly (LLY), Pfizer (PFE), and Intel (INTC), offering incentives like tariff relief in exchange for concessions. A key and novel aspect of this policy is the government taking direct equity stakes, exemplified by its 10% holding in Intel and a 15% stake in MP Materials (MP). To finance these interventions, the administration plans to quadruple the financing power of the International Development Finance Corporation to $250 billion and establish a U.S. Investment Accelerator with $550 billion from a trade deal with Japan. This new paradigm is creating both opportunities and uncertainty; while some firms are proactively seeking government partnerships, as evidenced by J.P. Morgan creating a dedicated task force, others express concern over potential equity demands and the risk of policy reversal under a future administration.

Key Decisions for Investors

• Investors should increase scrutiny on companies in targeted sectors like semiconductors, critical minerals, and pharmaceuticals, as government intervention could materially alter their competitive landscape and capital structure.
• For companies with direct government investment, such as Intel (INTC) and MP Materials (MP), valuation models must now incorporate the implications of government equity, including potential influence on corporate strategy and the stability of associated purchase agreements.
• A significant political risk premium should be factored into long-term investments in beneficiary companies, as the durability of these state-driven deals is questionable and subject to reversal by a subsequent administration.
• Monitor companies like Lithium Americas (LAC) and others in the domestic supply chain for critical materials, as they may represent unique opportunities if they secure favorable government loans or contracts, but weigh this against the risk of equity dilution.
• The active involvement of Wall Street veterans and firms like J.P. Morgan in facilitating these government deals indicates a new paradigm where political alignment is a growing factor for corporate success, warranting its inclusion in fundamental analysis.